Skip to content

Investigation of the Effectiveness of Upper Limb Exercise in COPD Patients

Investigation of the Effectiveness of Upper Limb Exercise in COPD Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03863717
Enrollment
44
Registered
2019-03-05
Start date
2017-12-14
Completion date
2020-05-31
Last updated
2020-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Brief summary

The aim of the study is to investigate the efficacy of upper limb exercise training in Chronic Obstructive Pulmonary Disease (COPD) patients. For the purpose of the study, a controlled trial will be conducted within Respiratory Clinic of Nicosia General Hospital. The sample will be divided in two groups. The intervention group will participate in a pulmonary rehabilitation program which includes upper and lower extremities exercises, with addition of arm ergometer. The second group (control group) will participate in the same program but without arm ergometer training. The study's hypothesis is that the intervention group will improve the outcome measures significantly better than the control group.

Interventions

OTHERArm Endurance Exercise Training

Pulmonary Rehabilitation Program including Upper Limb Endurance Exercise Training with arm cycle ergometer

OTHERControl

Pulmonary Rehabilitation Program without Upper Limb Endurance Exercise Training

Sponsors

Nicosia General Hospital
CollaboratorOTHER
European University Cyprus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of COPD confirmed by clinical examination and a pulmonary function test * Stable clinical condition (without recent respiratory system infections or any exacerbation of the disease) * Patients must be willing to re evaluate at the end of the study * Patients must be willing to give written consent for their participation in the study

Exclusion criteria

* Age \< 18 years old * Unstable cardiac disease * Musculoskeletal and neurological diseases that could affect exercise performance or preclude exercise * Patients of COPD final stage or other serious disease final stage * Significant cognitive or psychiatric impairment that would lead to an inability to follow simple commands in a group setting

Design outcomes

Primary

MeasureTime frameDescription
Upper Limb Muscle Strength, tricepsBefore InterventionAssess triceps via hand-held dynamometer Micro FET2
Upper Limb Muscle Strength, hand-gripBefore InterventionAssess via jamar hand dynamometer
Upper Limb Muscle Strength, biceps brachiiBefore InterventionAssess biceps brachii via hand-held dynamometer Micro FET2
Dyspnea, modified Borg ScaleBefore InterventionAssess via modified Borg Scale 0 - 10, 0 = no dyspnea, 10 = maximal dyspnea
Dyspnea, mMRC ScaleBefore InterventionAssess via modified Medical Research Council Dyspnea Scale 0 - 4, 0 = breathless only with strenuous exercise, 4 = too breathless to leave the house or breathless when dressing
FatigueBefore InterventionAssess via modified Borg Scale (0 - 10), 0 = no fatigue, 10 = maximal fatigue
Health-related Quality of Life, SGRQBefore InterventionAssess via Saint George Respiratory Questionnaire, A total score incorporates scores from each component of the SGRQ which ranges from 1 to 100, where 0 indicates best health and 100 indicates worst health
Health-related Quality of Life, CATBefore InterventionAssess via COPD Assessment Test (CAT), Range of CAT scores from 0-40. Higher scores denote a more severe impact of COPD on a patient's life.
Activities of Daily Living with Upper LimbsBefore InterventionAssess via total time need to perform 3 daily activities: (i) simulating of window cleaning, (ii) dry 10 dishes and putting them on a shelf above shoulder level and (iii) putting three packages, each weighing 1000 g, on a shelf above shoulder level

Countries

Cyprus

Contacts

Primary ContactChristos Karagiannis
c.karayiannis@euc.ac.cy0035799912547

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026